Insider Trading & Ownership - BELVIN MARCIA

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BELVIN MARCIA
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-20
Sale
2024-08-22
6:01 pm
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
4,181$1.2291$5,139175,648
(Direct)
View
2024-03-19
Sale
2024-03-21
4:37 pm
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
12,795$2.0855$26,684168,579
(Direct)
View
2023-12-20
Sale
2023-12-22
4:14 pm
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
4,077$1.3805$5,628155,124
(Direct)
View
2023-09-22
Sale
2023-09-22
7:16 pm
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
4,119$1.3003$5,356147,951
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-20
Exercise
2024-08-22
6:01 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
11,250$0175,648
(Direct)
View
2024-01-18
Option Award
2024-01-19
8:38 pm
N/A
2034-01-17
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
223,750$0378,874
(Direct)
View
2023-12-17
Exercise
2023-12-19
7:54 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
11,250$0170,451
(Direct)
View
2023-09-20
Option Award
2023-09-22
7:16 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
11,250$0147,951
(Direct)
View
2023-03-22
Option Award
2023-03-29
7:54 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
60,000$0140,820
(Direct)
View

Ownership
2023-03-29
7:50 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXBELVIN MARCIA
SVP, Chief Scientific Officer
0$0881,310
(Direct)
View